Targets › RNA
1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease; next expected readout Nov 2026.
Open in Phaseline: the race on RNA, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Ain Shams University | Clarithromycin Bacterial 70S ribosome inhibitor | RNA | Phase 2 | Helicobacter Pylori Infection | Nov 2026 |
Helicobacter Pylori Infection (1)
small molecule (1)
Ain Shams University (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.